← Grant listing · GrantsDue Pro

Public Health Crisis Response Cooperative Agreement

Centers for Disease Control - OPHPR · CDC-RFA-TP22-2201 · Deadline: February 11, 2027 · Advertised ceiling: $5M

Program-level history — this opportunity doesn't publish per-opportunity awards, so these numbers describe its parent program (CFDA 93.354, Public Health Emergency Response: Cooperative Agreement for Emergency Response: Public Health Crisis Response), not this competition alone. Labeled that way on purpose.

Ask-amount guidance

Applicants here typically receive far less than the advertised ceiling: the program median is $3.8M against a $5M ceiling (76%). Budgets far above the median need a story; budgets far below leave money on the table.

Draw-down reality (program)

Across 250 completed awards in this program (FY2021+ sample, USAspending outlay records), grantees ultimately drew a median 100% of obligated funds. A median well under 100% means underspend or early closure is common here — worth knowing before promising a spend-down timeline.

Listing summary

CDC seeks to enhance the nation’s ability to rapidly mobilize, surge, and respond to public health emergencies (PHEs) as identified by CDC by establishing a roster of approved but unfunded (ABU) applicants that may receive rapid funding to respond to PHEs of such magnitude, complexity, or significance that they would have an overwhelming impact upon, and exceed resources available to, the jurisdictions. Applicants will undergo an objective merit review process, and entities that successfully meet the requirements for approval will be placed on the ABU list. CDC will use this ABU list for emerg…

Eligibility: State governments, County governments, City or township governments, Special district governments, Native American tribal governments (Federally recognized), Others · Categories: Health · official listing ↗

Sources: NIH RePORTER (opportunity-exact) and USAspending (program-level), labeled per section. GrantsDue computes summaries only; verify anything critical against the originals. Methodology.